SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-10
👔
Evommune, Inc.
@EVMN_InsiderForm 4 Filing: Carver Kyle Buys $13,260 of $EVMN
INSIDER PURCHASE
⚡ MATERIALITY: 6/10
corporate issuer
Evommune, Inc.
Ticker: $EVMN
Transaction Value
$13,260
Price/Share: $13.26
transaction date
2026-07-08
Shares: 1,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Carver Kyle, holds the title of Chief Financial Officer at Evommune, Inc..
On 2026-07-08, the insider transacted 1,000 shares.The shares were transacted at a weighted average price of $13.26 per share, resulting in a total market-relevant value of $13,260.
Executive Summary Summary
Carver Kyle (Chief Financial Officer) bought $13K of $EVMN
Post-Transaction Position: 60,335 shares
SEC Accession No: 0001757072-26-000007 (CIK: 1757072)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.